Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Erratum: Evaluation of the characteristics of infection prevention and control programs and infection control committees in Brazilian hospitals: A countrywide cross-sectional study - CORRIGENDUM.
Arns B, Agani CAJO, Sesin GP, Horvath JDC, Fogazzi DV, Romeiro Silva FK, Costa LS, Pereira AJ, Nassar Junior AP, Cavalcanti BT, Dietrich C, Veiga VC, Catarino DGM, Cheno MY, Biasi A, Ferronatto BR, Bassetti BR, Fernandes CCF, Deutschendorf C, Grion CMC, Vidal CFL, de Oliveira CD, Caser EB, Boschi E, Silva EM, Pizzol FD, Urbano HCA, Silva I, Maia IS, Rego LRM, Oliveira LP, Tavares MB, Dracoulakis MDA, Bainy MP, Golin NA, Tomba PO, Kurtz PMP, Foernges RB, Prestes RM, de Melo RMV, Da Silva RR, Toledo TGP, Lima VP, Fernandes VF, Lovato WJ, Zavascki AP. Arns B, et al. Among authors: pizzol fd. Antimicrob Steward Healthc Epidemiol. 2023 Jun 19;3(1):e102. doi: 10.1017/ash.2023.189. eCollection 2023. Antimicrob Steward Healthc Epidemiol. 2023. PMID: 37396195 Free PMC article.
Pharmacokinetic analysis of vilobelimab, anaphylatoxin C5a and antidrug antibodies in PANAMO: a phase 3 study in critically ill,  invasively mechanically ventilated COVID-19 patients.
Lim EHT, Vlaar APJ, de Bruin S, Rückinger S, Thielert C, Habel M, Guo R, Burnett BP, Dickinson J, Brouwer MC, Riedemann NC, van de Beek D; PANAMO study group. Lim EHT, et al. Intensive Care Med Exp. 2023 Jun 19;11(1):37. doi: 10.1186/s40635-023-00520-8. Intensive Care Med Exp. 2023. PMID: 37332066 Free PMC article.
Evaluation of the characteristics of infection prevention and control programs and infection control committees in Brazilian hospitals: A countrywide cross-sectional study.
Arns B, Agani CAJO, Sesin GP, Horvath JDC, Fogazzi DV, Romeiro Silva FK, Costa LS, Pereira AJ, Nassar Junior AP, Cavalcanti BT, Dietrich C, Veiga VC, Catarino DGM, Cheno MY, Biasi A, Ferronatto BR, Bassetti BR, Fernandes CCF, Deutschendorf C, Grion CMC, Vidal CFL, de Oliveira CD, Caser EB, Boschi E, Silva EM, Pizzol FD, Urbano HCA, Silva I, Maia IS, Rego LRM, Oliveira LP, Tavares MB, Dracoulakis MDA, Bainy MP, Golin NA, Tomba PO, Kurtz PMP, Foernges RB, Prestes RM, de Melo RMV, Da Silva RR, Toledo TGP, Lima VP, Fernandes VF, Lovato WJ, Zavascki AP. Arns B, et al. Among authors: pizzol fd. Antimicrob Steward Healthc Epidemiol. 2023 Apr 26;3(1):e79. doi: 10.1017/ash.2023.136. eCollection 2023. Antimicrob Steward Healthc Epidemiol. 2023. PMID: 37179767 Free PMC article.
Attributable mortality due to nosocomial sepsis in Brazilian hospitals: a case-control study.
Zampieri FG, Cavalcanti AB, Taniguchi LU, Lisboa TC, Serpa-Neto A, Azevedo LCP, Nassar AP Jr, Miranda TA, Gomes SPC, de Alencar Filho MS, da Silva RTA, Lacerda FH, Veiga VC, de Oliveira Manoel AL, Biondi RS, Maia IS, Lovato WJ, de Oliveira CD, Pizzol FD, Filho MC, Amendola CP, Westphal GA, Figueiredo RC, Caser EB, de Figueiredo LM, de Freitas FGR, Fernandes SS, Gobatto ALN, Paranhos JLR, de Melo RMV, Sousa MT, de Almeida GMB, Ferronatto BR, Ferreira DM, Ramos FJS, Thompson MM, Grion CMC, Santos RHN, Damiani LP, Machado FR; MAPA investigators, the BRICNet. Zampieri FG, et al. Among authors: pizzol fd. Ann Intensive Care. 2023 Apr 26;13(1):32. doi: 10.1186/s13613-023-01123-y. Ann Intensive Care. 2023. PMID: 37099045 Free PMC article.
Sepsis in Brazilian emergency departments: a prospective multicenter observational study.
Machado FR, Cavalcanti AB, Braga MA, Tallo FS, Bossa A, Souza JL, Ferreira JF, Pizzol FD, Monteiro MB, Angus DC, Lisboa T, Azevedo LCP; SPREAD ED Investigators, the Instituto Latino Americano de Sepsis Network. Machado FR, et al. Among authors: pizzol fd. Intern Emerg Med. 2023 Mar;18(2):409-421. doi: 10.1007/s11739-022-03179-3. Epub 2023 Feb 2. Intern Emerg Med. 2023. PMID: 36729268
Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.
Vlaar APJ, Witzenrath M, van Paassen P, Heunks LMA, Mourvillier B, de Bruin S, Lim EHT, Brouwer MC, Tuinman PR, Saraiva JFK, Marx G, Lobo SM, Boldo R, Simon-Campos JA, Cornet AD, Grebenyuk A, Engelbrecht JM, Mukansi M, Jorens PG, Zerbib R, Rückinger S, Pilz K, Guo R, van de Beek D, Riedemann NC; PANAMO study group. Vlaar APJ, et al. Lancet Respir Med. 2022 Dec;10(12):1137-1146. doi: 10.1016/S2213-2600(22)00297-1. Epub 2022 Sep 7. Lancet Respir Med. 2022. PMID: 36087611 Free PMC article. Clinical Trial.
26 results